136 related articles for article (PubMed ID: 25946589)
1. [Cost of breast cancer treatment by clinical stage in the Basque Country, Spain].
Arrospide A; Soto-Gordoa M; Acaiturri T; López-Vivanco G; Abecia LC; Mar J
Rev Esp Salud Publica; 2015; 89(1):93-7. PubMed ID: 25946589
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis.
Arrospide A; Rue M; van Ravesteyn NT; Comas M; Soto-Gordoa M; Sarriugarte G; Mar J
BMC Cancer; 2016 Jun; 16():344. PubMed ID: 27251556
[TBL] [Abstract][Full Text] [Related]
3. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
Moger TA; Bjørnelv GM; Aas E
Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.
Delgado-Ortega L; González-Domínguez A; Borrás JM; Oliva-Moreno J; González-Haba E; Menjón S; Pérez P; Vicente D; Cordero L; Jiménez M; Simón S; Hidalgo-Vega Á; Moya-Alarcón C
Eur J Health Econ; 2019 Feb; 20(1):135-147. PubMed ID: 29922900
[TBL] [Abstract][Full Text] [Related]
6. Direct medical costs of breast cancer in Jordan: cost drivers and predictors.
Mousa R; Hammad E; Melhem J; Al-Jaghbir M
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):647-654. PubMed ID: 33353434
[No Abstract] [Full Text] [Related]
7. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing.
Wilkinson AN; Seely JM; Rushton M; Williams P; Cordeiro E; Allard-Coutu A; Look Hong NJ; Moideen N; Robinson J; Renaud J; Mainprize JG; Yaffe MJ
Curr Oncol; 2023 Aug; 30(9):7860-7873. PubMed ID: 37754486
[TBL] [Abstract][Full Text] [Related]
8. Costs, effects and cost-effectiveness of breast cancer control in Ghana.
Zelle SG; Nyarko KM; Bosu WK; Aikins M; Niëns LM; Lauer JA; Sepulveda CR; Hontelez JA; Baltussen R
Trop Med Int Health; 2012 Aug; 17(8):1031-43. PubMed ID: 22809238
[TBL] [Abstract][Full Text] [Related]
9. Cost of breast cancer treatment. A 4-year longitudinal study.
Legorreta AP; Brooks RJ; Leibowitz AN; Solin LJ
Arch Intern Med; 1996 Oct; 156(19):2197-201. PubMed ID: 8885818
[TBL] [Abstract][Full Text] [Related]
10. A workplace breast cancer screening program. Costs and components.
Schrammel P; Griffiths RI; Griffiths CB
AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
[TBL] [Abstract][Full Text] [Related]
11. Costs of breast cancer treatment prior to the introduction of immune-based therapy in Mexico.
Meneses-García A; Ramírez T; Ruiz-Godoy L; Chiquete E; Mohar A
Rev Med Inst Mex Seguro Soc; 2012; 50(1):19-24. PubMed ID: 22768813
[TBL] [Abstract][Full Text] [Related]
12. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Skrundevskiy AN; Omar OS; Kim J; Soliman AS; Korolchuk TA; Wilson FA
Value Health Reg Issues; 2018 Sep; 16():22-27. PubMed ID: 29626738
[TBL] [Abstract][Full Text] [Related]
13. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
14. [Standard treatment cost of female breast cancer at different TNM stages].
Li H; Huang Y; Huang R; Li JY
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):946-50. PubMed ID: 24506967
[TBL] [Abstract][Full Text] [Related]
15. Cost of breast cancer based on real-world data: a cancer registry study in Italy.
Capri S; Russo A
BMC Health Serv Res; 2017 Jan; 17(1):84. PubMed ID: 28122558
[TBL] [Abstract][Full Text] [Related]
16. Will early detection of breast cancer reduce the costs of treatment?
Salkeld G; Gerard K
Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
[TBL] [Abstract][Full Text] [Related]
17. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
[TBL] [Abstract][Full Text] [Related]
18. Estimates of the lifetime costs of breast cancer treatment in Canada.
Will BP; Berthelot JM; Le Petit C; Tomiak EM; Verma S; Evans WK
Eur J Cancer; 2000 Apr; 36(6):724-35. PubMed ID: 10762744
[TBL] [Abstract][Full Text] [Related]
19. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
20. Global treatment costs of breast cancer by stage: A systematic review.
Sun L; Legood R; Dos-Santos-Silva I; Gaiha SM; Sadique Z
PLoS One; 2018; 13(11):e0207993. PubMed ID: 30475890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
